GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

InterCure INCR.TA · ILA

Health Care · Tel Aviv · 🇮🇱 Israel

Compare

1,088.00

+4.02%

Close of 9 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in ILS, from our data supplier.

FY2024

Revenue

ILS 238.8m

FY2016FY2024

Net income

−ILS 67.8m

FY2016FY2024

Free cash flow

−ILS 71.8m

FY2016FY2024

Shareholders' equity

—

FY2016FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueILS 238.8mILS 355.6mILS 388.7mILS 219.7mILS 65.0mILS 8.9m———
Research and developmentILS 414,000ILS 388,000ILS 632,000ILS 1.2mILS 1.6mILS 1.7m———
Operating income−ILS 49.3mILS 31.7mILS 63.4mILS 39.5m−ILS 40.0m−ILS 3.1m−ILS 10.6m−ILS 4.2mILS 1.1m
Net income−ILS 67.8m−ILS 62.0mILS 44.8mILS 4.7m−ILS 37.2m−ILS 5.9m−ILS 12.8m−ILS 5.5mILS 251,000
Diluted earnings per share-1.48-1.360.990.10-1.42-0.25-0.71-0.330.02

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets——ILS 958.0mILS 696.5mILS 326.3mILS 282.2mILS 35.9mILS 25.1mILS 24.7m
Cash and short-term investments——ILS 232.8mILS 196.5mILS 38.3mILS 27.5mILS 3.7mILS 2.6mILS 2.9m
Total liabilities——ILS 456.7mILS 248.5mILS 51.8mILS 26.3mILS 16.3mILS 3.4mILS 3.3m
Debt——ILS 255.2mILS 105.6mILS 6.7mILS 17.1mILS 12.8mILS 3.1mILS 2.1m
Shareholders' equity——ILS 501.3mILS 448.0mILS 274.5mILS 256.0mILS 19.7mILS 21.7mILS 21.4m
Shares outstanding46m46m45m47m26m23m18m17m13m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−ILS 66.9m−ILS 53.6mILS 51.3mILS 30.1mILS 7.8m−ILS 11.6m−ILS 1.5m−ILS 966,000−ILS 1.1m
Capital spending−ILS 4.8m−ILS 2.6m−ILS 19.7m−ILS 14.0m−ILS 20.8m−ILS 28.1m−ILS 93,000—−ILS 7,000
Free cash flow−ILS 71.8m−ILS 56.3mILS 31.5mILS 16.1m−ILS 13.0m−ILS 39.7m−ILS 1.6m−ILS 966,000−ILS 1.1m

Latest quarters

By quarter end

Dec 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021
RevenueILS 355.6mILS 102.4mILS 106.2mILS 105.6mILS 100.6mILS 95.3mILS 87.2mILS 79.7m
Operating income−ILS 35.7mILS 6.9mILS 8.2mILS 10.9mILS 14.0mILS 17.4mILS 16.5mILS 17.8m
Net income−ILS 62.0mILS 4.9mILS 214,000ILS 8.6mILS 7.3mILS 15.6mILS 13.4m−ILS 3.1m
Diluted earnings per share-1.360.100.010.190.160.340.36-0.07
Total assetsILS 786.6mILS 841.8mILS 875.7mILS 958.0mILS 874.8mILS 793.1mILS 743.7mILS 696.5m
Cash and short-term investmentsILS 101.3mILS 102.8mILS 106.6mILS 232.8mILS 215.5mILS 221.5mILS 210.1mILS 196.5m
DebtILS 102.8mILS 106.3mILS 119.5mILS 123.9mILS 66.2mILS 69.2mILS 37.0mILS 35.0m
Shareholders' equityILS 455.1mILS 508.8mILS 502.9mILS 501.3mILS 490.0mILS 479.0mILS 461.8mILS 448.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.8%93.0%—
Operating income—74.1%—
Net income—63.0%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-3.0%7.1%3.3%—
Net margin-21.8%-6.7%-9.7%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2013FY2012
Price to earnings-20.1-16.961.1—-57.4-327.6-158.0-25.2-10.53.2
Price to sales5.72.97.022.132.9216.3——8.416.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 4.4493-to-1 reverse split · 8 Apr 2021
  • 10-to-1 reverse split · 8 Feb 2015
  • 2000-to-1 reverse split · 15 Jul 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.